Opsonix

Opsonix

Developing a broad-spectrum pathogen-extracting therapy to transform the treatment of sepsis.

Launch date
Employees
Market cap
-
Enterprise valuation
$32—48m (Dealroom.co estimates Oct 2015.)
Cambridge Massachusetts (HQ)
  • Edit
DateInvestorsAmountRound

$8.0m

Series A
Total Funding$8.0m

Recent News about Opsonix

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.